Effects of seasonality and treatment on COPD clinical outcomes: IMPACT post hoc analysis

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Conflict of interest: Gerard J. Criner reports support for the present manuscript from GSK. Consulting fees from Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, CSA Medical, Eolo, GSK, HGE Technologies, Novartis, Nuvaria, Olympus, Pulmonx, Verona, outside the submitted work.

Conflict of interest: David A. Lipson reports support for the present manuscript from GSK, holds GSK stocks/shares and is a GSK employee.

Conflict of interest: Lee Tombs reports support for the present manuscript from GSK. Other financial or non-financial interests outside the submitted work: Director of Other financial or non-financial interests, and consultant for Veramed.

Conflict of interest: MeiLan K. Han reports support for the present manuscript from GSK. Grants or contracts from NIH, Sanofi, Novartis, Nuvaira, Sunovion, Gala Therapeutics, COPD Foundation, AstraZeneca, American Lung Association, Boehringer Ingelheim, Biodesix, outside the submitted work; Royalties or licenses for Uptodate, Norton Publishing, Penguin Random House, outside the submitted work; consulting fees from AstraZeneca, Boehringer Ingelheim, GSK, Novartis, Pulmonx, Teva, Verona, Merck, Mylan, Sanofi, DevPro, Aerogen, Polarian, Regeneron, Altesa BioPharma, Amgen, Roche, United Therapeutics, RS Biotherapeutics, Apreo Health, outside the submitted work; Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events for Cipla, Chiesi, AstraZeneca, Boehringer Ingelheim, GSK, Medscape, Integrity, NACE, Medwiz, outside the submitted work; Participation on a Data Safety Monitoring Board or Advisory Board for Novartis, Medtronic, outside the submitted work; Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: COPD Foundation Board, COPD Foundation Scientific Advisory Committee, ALA advisory committee, American Thoracic Society journal editor, ALA volunteer spokesperson, GOLD scientific committee, Emerson School Board, Ann Arbor, MI, outside the submitted work; Stock or stock options for Meissa Vaccines, Altesa BioPharma, outside the submitted work; Writing support received from GSK, Boehringer Ingelheim, AstraZeneca, Novartis, outside the submitted work.